Search Results

Celebrating its past, European Medicines Agency looks to the future of public communication.

• Authors : Mbaeliachi, Nacho¹

• Source: Medical Writing. Jun2025, Vol. 34 Issue 2, p18-20. 3p.

Record details

Phytotherapy for pain and/or inflammation associated with the musculoskeletal system according to the recommendations of the European Medicines Agency

• Authors : Weronika Krasocka; Anna Marchelak; Anna Magiera

• Source: Farmacja Polska. 80:851-870

Record details

European Medicines Agency Conflicts With the European Food Safety Authority (EFSA) on Bisphenol A Regulation

• Authors : Zoeller, R. Thomas, 1952; Birnbaum, Linda S.; Collins, Terrence J.

Subjects: BPA; EDCs; European Food Safety Authority

• Source: Journal of the Endocrine Society. 7(9)

Record details

The EMA as a potential driver of competitiveness of orphan medicines in Europe: a focus on regulatory incentives and funding opportunities.

• Authors : Gomez-Ferreria, Maria Ana¹ (AUTHOR) ; Garcia-Muñoz, Virginia¹ (AUTHOR); Zwiers, Alex¹ (AUTHOR)

• Source: Orphanet Journal of Rare Diseases. 10/28/2025, Vol. 20 Issue 1, p1-5. 5p.

Record details

Planning a clinical trial programme for medicinal products for chronic constipation: An analysis of the European Medicines Agency Guideline

• Authors : I. A. Proskurina; T. E. Gorskaya; R. S. Ilin

Subjects: chronic constipation; clinical trial; medicinal product

• Source: Регуляторные исследования и экспертиза лекарственных средств, Vol 15, Iss 2, Pp 229-240 (2025)

Record details

Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard.

• Authors : Konkle, Barbara A.¹ (AUTHOR); Peyvandi, Flora² (AUTHOR); Coffin, Donna³ (AUTHOR)

• Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p232-235. 4p.

Record details

Insights from the European Medicines Agency on digital health technology derived endpoints

• Authors : Jadoenathmisier, Keerti D.; Gardarsdottir, Helga; Mol, Peter G.M.

Subjects: Decentralized trial elements; Digital biomarkers; Digital health technologies

• Source: Jadoenathmisier, K D, Gardarsdottir, H, Mol, P G M & Pasmooij, A M G 2025, 'Insights from the European Medicines

Record details

From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018–2022)

• Authors : Sarah Sauchelli; Courtney Levy; Ari Gnanasakthy

Subjects: patient-reported outcome (PRO); European Medicines Agency (EMA); summary of product characteristics (SmPC)

• Source: Frontiers in Pharmacology, Vol 16 (2025)

Record details

Comparative Analysis of Personalized Medicine Regulatory Frameworks and Challenges in the Usa and Europe.

• Authors : Tanvi, Katikala¹ ; Mishra, Sangita² ; Venkatesh, M. P.³

• Source: Journal of Neonatal Surgery. 2025 Supplement, Vol. 14, p318-330. 13p.

Record details

Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017–2022

• Authors : Ciani, Oriana; Meregaglia, Michela; Battaglia, Mario Alberto ...

Subjects: Europe; Patient-reported outcomes; Cross-Sectional Studies

• Source: Neurol Sci

Record details